ArticleBMC cancer2018
Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Jie Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it